| Literature DB >> 33805184 |
Antia G Pereira1,2, Maria Fraga-Corral1,2, Paula Garcia-Oliveira1,2, Catarina Lourenço-Lopes1, Maria Carpena1, Miguel A Prieto1,2, Jesus Simal-Gandara1.
Abstract
In the recent decades, algae have proven to be a source of different bioactive compounds with biological activities, which has increased the potential application of these organisms in food, cosmetic, pharmaceutical, animal feed, and other industrial sectors. On the other hand, there is a growing interest in developing effective strategies for control and/or eradication of invasive algae since they have a negative impact on marine ecosystems and in the economy of the affected zones. However, the application of control measures is usually time and resource-consuming and not profitable. Considering this context, the valorization of invasive algae species as a source of bioactive compounds for industrial applications could be a suitable strategy to reduce their population, obtaining both environmental and economic benefits. To carry out this practice, it is necessary to evaluate the chemical and the nutritional composition of the algae as well as the most efficient methods of extracting the compounds of interest. In the case of northwest Spain, five algae species are considered invasive: Asparagopsis armata, Codium fragile, Gracilaria vermiculophylla, Sargassum muticum, and Grateulopia turuturu. This review presents a brief description of their main bioactive compounds, biological activities, and extraction systems employed for their recovery. In addition, evidence of their beneficial properties and the possibility of use them as supplement in diets of aquaculture animals was collected to illustrate one of their possible applications.Entities:
Keywords: aquaculture feed; biological activity; invasive macroalgae species; metabolites; seaweeds
Year: 2021 PMID: 33805184 PMCID: PMC8064379 DOI: 10.3390/md19040178
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Properties and applications of extracts and compounds isolated from algae in the cosmetic field.
| Treatment | Specie | Compound | Result | Ref. |
|---|---|---|---|---|
| Skin aging |
| Extract | Decline the amount of progerin in aged fibroblasts at the lowest tested concentration (not for younger cells) | [ |
|
| Ethanol extract | Protecting the skin from the adverse effects of UV exposure; preventing and/or delaying the appearance of skin aging effects | [ | |
|
| Fucosterol | Inhibit metalloproteinase-1 expression | [ | |
|
| Phlorotannins | Inhibit metalloproteinase-1 expression | [ | |
| Sunscreen |
| Phlorotannins | UV-filter activity | [ |
|
| Phlorotannins | Protective effect against photo-oxidative stress | [ | |
|
| Phenolic compounds | Anti-photoaging activity and inhibition of matrix metalloproteinase | [ | |
| Fucoxanthin | Protective effect on UV-B induced cell damage | [ | ||
|
| Fucoidan | Suppress photo-oxidative stress and skin barrier perturbation in UVB-induced human keratinocytes | [ | |
| Acetone extracts | In vivo UVB-photoprotective activity | [ | ||
| Moisturizer |
| Fucoidan | Inhibition of hyaluronidase enzyme | [ |
|
| 5% water:propylene glycol (50:50) extracts | Hydration with the alga extract increased by 14.44% compared with a placebo | [ | |
|
| Polysaccharides and amino acids | Similar moisturizing effects to hyaluronic acid and glycerin | [ | |
| Whitening |
| Zeaxanthin | Antityrosinase activity | [ |
|
| Fucoxanthin | Antityrosinase activity | [ | |
|
| Ethanol extract | Antityrosinase activity | [ | |
| Hair care | Intact microalga cells | Soften and make flexible both skin and hair | [ | |
|
| Dioxinodehydroeckol | Promote hair growth | [ |
Invasive algae species in Spain: taxonomy, origin, geographical distribution, and principal uses.
| Specie | Taxonomy | Native Distribution | Distribution in Spain | Other Regions in Which They are Invasive | Principal Uses |
|---|---|---|---|---|---|
| Red species | |||||
|
| Phylum: | Western Australia | All Spain | Temperate coastlines on the Pacific coast of North America and western coasts of Europe | - Unknown |
|
| Phylum: | Indo-Pacific Ocean | All Spain | Mediterranean, Portugal, and Ireland | - Pharmaceutical potential as antibiotic |
|
| Phylum: | Australia and New Zealand | Except Canarias | Portugal | - Human consumption |
|
| Phylum: | Pacific Ocean | All Spain | North America, Europe, and Oceania | - Human consumption |
|
| Phylum: | Indo-Pacific Ocean | All Spain | Mediterranean | - Unknown |
|
| Phylum: | Indo-Pacific Ocean | All Spain | Mediterranean | - Unknown |
| Brown species | |||||
|
| Phylum: | North-east Pacific | All Spain | Europe and North America | - Animal feed |
|
| Phylum: | Indo-Pacific Ocean | All Spain | Pacific Coast of North America, North Sea, Portugal, and the Mediterranean | - Animal feed |
|
| Phylum: | Indo-Pacific Ocean and Red Sea | All Spain | Africa and Southwest Asia | - Unknown |
|
| Phylum: | Asia | All Spain | Europe | - Human consumption |
| Green species | |||||
|
| Phylum: Chlorophyta | Tropical area | All Spain | Mediterranean, California, and southern Australia | - Laboratory use |
|
| Phylum: Chlorophyta | North of the Pacific Ocean and coast of Japan | All Spain | Widespread in the Mediterranean | - Human consumption |
|
| Phylum: Chlorophyta | Tropical areas | Except Canarias | Mediterranean: from Spain to Turkey | - Human consumption |
| Diatoms | |||||
|
| Phylum: Ochrophyta | Boreal and alpine regions of North America and Northern Europe | All Spain | New Zealand and Patagonia, South America | - Ornamental |
Main compounds and bioactive compounds reported for the invasive macroalgae in northwest Spain.
| Bioactive compounds | Invasive Macroalgae | ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
|
|
|
|
|
| |
| Polysaccharides | Sulphated galactan derivatives, Mannitol | Sulphated polysaccharides | Fucoidans, Alginate, Glucuronic acid, Mannuronic acid, Laminarin | ||
| Lipids | Cholestanol, Cholesta-5,25-diene-3,24 -diol, Palmitic acid, Stearic acid | Clerosterol | Cholesterol, 1-tetradecanol, 1-hexadecanol, 1-octadecanol, 1-eicosanol, 1-docosanol, Sterols, Monoacylglycerol | α -Linolenic acid | Phospholipids, Glycolipids, Eicosapentaenoic acid |
| Proteins | Mycrosporine-like aminoacids* | ||||
| Pigments | β-carotene, Siphonaxanthin | Fucoxanthin | R-phycoerythrin | ||
| Vitamins | α, β, γ, δ-tocopherol, γ-tocotrienol | α-tocopherol | α, γ-tocopherol | α-tocopherol, Phytonadione (vitamin K1) | |
| Phenolic compounds | Not specified | Flavonoids, tannins | Gallic acid, Protocatechuic acid, Gentisic acid, Hydroxybenzoic acid, vVnillic acid, Syringic acid | Hydroxybenzoic acid, Gallic acid, Vanillic acid, Protocatechuic acid, Caffeic acid, Syringic acid, Chlorogenic acid, Coumaric acid, Phlorotannins, Fuhalols, Phlorethols, Hydroxyfuhalols, Monofuhalol A, | |
| Other compounds | Halogenated compounds, | Serine protease | Long chain aliphatic alcohols | Tetrapernyltaluquinol meroterpenoid with a chrome moiety | Squalene |
| Reference | [ | [ | [ | [ | [ |
Extraction techniques for obtaining bioactive compounds from the invasive macroalgae in northwest Spain.
| Method | Conditions | Compounds | Activities | Model/Assay | Ref. |
|---|---|---|---|---|---|
|
| |||||
| Soxhlet | Chloroform-methanol (3:2), dichloromethane (100%), methanol (100%), and water (100%), 8 h | - | Anti-Herpes Simplex Virus and cytotoxicity | Neutral red dye method on Vero cells. | [ |
| Mac | Hexane, dichloromethane, and ethanol | Halogenated compounds | Antiprotozoal | [ | |
| Mac | 0.025 g/mL; methanol, 16 h, 20 °C | Phenolic compounds | Antioxidant and neuroprotective | DPPH, CCA, ICA. AChE, BuChE, TYRO inhibition. | [ |
| HAE | 0.04 g/mL; distilled water, 5 h, 96 °C | Polysaccharides | Anti-HIV | Human immunodeficiency virus (HIV) induced syncytium formation on MT4 cells. | [ |
| PLE | Dichloromethane methanol (1:1; v:v); 75 °C, 1500 psi, 7 min (×2) | Phenolic compounds | Antioxidant and cytotoxicity | Radical-scavenging activity (DPPH). Reducing activity. Daudi, Jurkat and K562 cell lines. | [ |
|
| |||||
| Mac | 80% methanol (×3). Butanol and ethyl-acetate fractions. | Clerosterol | Antioxidant and anti-inflammatory | In vivo MTT assay on human keratinocyte HaCaT cells irradiated with UVB and BALB/c mice models. Expression of pro-inflammatory proteins and mediators | [ |
| Mac | Hexane, ethyl, and methanol (×3) | - | Antioxidant and anti-hypertensive | DPPH and ABTS inhibition | [ |
| Mac | 80% methanol | - | Anti-inflammatory | Lipopolysaccharide-stimulated RAW 264.7 | [ |
| Mac | 80% methanol | - | Anti-cancer | Human breast cancer cell line MDA-MB-231 | [ |
| HAE | 0.02 g/mL; water, 12 h, 60 °C | Polysaccharides | Anticoagulant | APTT assay on human blood | [ |
| HAE | 10 vol, distilled water, 1 h, 95 °C | - | Anti-inflammatory and anti-edema | LPS-stimulated RAW 264.7 and carrageenan-induced paw edema in male Sprague-Dawley rats. | [ |
| HAE | Ethanol 96% ( | - | Anti-inflammatory | LPS-stimulated RAW 264.7. | [ |
| HAE | Distilled water, 4 h, 90 °C. | - | Anti-inflammatory, alleviation of cartilage destruction | Primary chondrocytes cells, osteoarthritis rat model. | [ |
|
| |||||
| Mac | 0.1 g/mL; water or ethanol, 96%, 12 h, room temperature. | Phenolic compounds | Antioxidant | In vitro assays (DPPH, FRAP, ferrous ion-chelating) and liposome model system. | [ |
| Soxhlet | 0.3 g/mL; ethyl acetate; 72 h. | - | Antimicrobial | Strains of | [ |
|
| |||||
| S/L | 1/20 ratio ( | - | Antibacterial | European abalone pathogen | [ |
|
| |||||
| Mac | 0.01 g/mL; 80% methanol, 24 h, RT. | Fucoxanthin | Anti-inflammatory | LPS-stimulated RAW 264.7 macrophages | [ |
| Mac | 0.1 g/mL; Water or ethanol, 96%, 12 h, RT. | Phenolic compounds | Antioxidant | In vitro assays (DPPH, FRAP, ferrous ion-chelating) and liposome model system | [ |
| Mac | Dichloromethane or methanol, 1:4 ( | Phenolic compounds | Antioxidant and cytoprotective effect | In vitro assays (DPPH and ORAC) | [ |
| HAE | Methanol:water (1:10), 3 h, 65 °C (×3) | Chromane meroterpenoid | Photodamage attenuation | Human dermal fibroblasts | [ |
| SFE | CO2, 10% ethanol, 15.2 MPa, 60 °C, 90 min (static) | - | Antioxidant | Not reported | [ |
| PLE | Ethanol:water (95:5); 160 °C, 10.3 MPa, 20 min (×2) | Phlorotannins | Antiproliferative | HT-29 adenocarcinoma colon cancer cells | [ |
| UAE | Water at S/L ratio of 1:20; 5–30 min, RT (25 °C), 5 A, 150 W and 40 Hz. | Alginate | Cytotoxic effect | A549, HCT- 116, PSN1, and T98G cells | [ |
| Autohydrolisis | 96% ethanol | - | Antioxidant, anti-inflammatory and anti-irritant | In vitro assays (FRAP, DPPH and ABTS). Reconstructed human epidermis test method. Irritability assays with the Episkin test. | [ |
| Autohydrolisis | RT, formaldehyde 1% (15 h), sulfuric acid 0.2 N (4 h), and sodium carbonate 1% (15 h). | Phlorotannins | Anti-tumor and anti-inflammatory | A549, HCT-116, PSN1, and T98G cells. Neutrophils’ oxidative burst oxidation of luminol. | [ |
Extraction method: PLE: pressurized liquid extraction; S/L: solid–liquid; SFE: supercritical fluid extraction; UAE: ultrasound assisted extraction; Mac: maceration; RT: room temperature. Assays: DPPH: 1,1-Diphenyl-2-picrylhydrazyl; ABTS: 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid; CCA: copper chelating activity; ICA: iron chelating activity; AChE: acetylcholinesterase; BuChE: butyrylcholinesterase; TYRO: tyrosinase; ACE: angiotensin converting enzyme; APTT: activated partial thromboplastin Time; ORAC: oxygen radical absorbent capacity; FRAP: ferric antioxidant power. Cell lines: Vero: African green monkey kidney cell line; MT4: leukemia cell line; HaCaT: aneuploid immortal keratinocyte cell line; RAW 264.7: murine macrophage cell line; MCF-7: human breast cancer cell line; A549: adenocarcinomic human alveolar basal epithelial cells; HCT-116: human colon cancer cell line; PSN1: human pancreatic cancer cell line; T98G: glioblastoma cell line.